Serological relationship between cutaneous human papillomavirus types 5, 8 and 92
about
HPV vaccination for prevention of skin cancer.Chimeric L2-Based Virus-Like Particle (VLP) Vaccines Targeting Cutaneous Human Papillomaviruses (HPV)A quadrivalent HPV vaccine induces humoral and cellular immune responses in WHIM immunodeficiency syndrome.Efficacy of RG1-VLP vaccination against infections with genital and cutaneous human papillomaviruses.Review: antibodies to cutaneous human papillomaviruses.Cutaneous Papillomaviruses and Non-melanoma Skin Cancer: Causal Agents or Innocent Bystanders?
P2860
Serological relationship between cutaneous human papillomavirus types 5, 8 and 92
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Serological relationship between cutaneous human papillomavirus types 5, 8 and 92
@en
Serological relationship between cutaneous human papillomavirus types 5, 8 and 92.
@nl
type
label
Serological relationship between cutaneous human papillomavirus types 5, 8 and 92
@en
Serological relationship between cutaneous human papillomavirus types 5, 8 and 92.
@nl
prefLabel
Serological relationship between cutaneous human papillomavirus types 5, 8 and 92
@en
Serological relationship between cutaneous human papillomavirus types 5, 8 and 92.
@nl
P2093
P2860
P356
P1476
Serological relationship between cutaneous human papillomavirus types 5, 8 and 92
@en
P2093
Alessandra Handisurya
Christina Schellenbacher
Michel Favre
Ola Forslund
Ratish Gambhira
Reinhard Kirnbauer
Saeed Shafti-Keramat
P2860
P304
P356
10.1099/VIR.0.006189-0
P407
P577
2009-01-01T00:00:00Z